Ampio Pharmaceuticals is engaged in the discovery and development of pharmaceutical drugs and diagnostic products to address metabolic disorders, eye diseases, kidney diseases, acute and chronic inflammation diseases, and male sexual dysfunction. Its products include Optina, to treat diabetic retinopathy, diabetic macular edema, and hereditary angioedema; Vasaloc for the treatment of diabetic nephropathy; Zertane, for the treatment of male sexual dysfunction; and Ampion, for the treatment of chronic inflammatory and autoimmune diseases. The company is also developing a handheld oxidation-reduction potential diagnostic device. For more information, visit the company’s Web site at: www.ampiopharma.com

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its ninth annual equity conference at The Hard Rock Hotel in Ft. Lauderdale, FL. Attended by institutional investors from across North America, the event features 135 public company executive teams with an emphasis on healthcare, technology, defense, and new-media / entertainment sectors.

Let us hear your thoughts below: